Taken together, these data provide compelling evidence that 2i broadly inhibits UHRF1 and DNMT1 expression in cancer cells by inhibition of the MEK/ERK pathway, which is broadly required for elevated transcription of both UHRF1 and DNMT1 in various cancer cells. Here, MAP2K7 is linked to cancer.